Endocrine-disrupting chemicals and public health protection: a statement of principles from The Endocrine Society.

An endocrine-disrupting chemical (EDC) is an exogenous chemical, or mixture of chemicals, that can interfere with any aspect of hormone action. The potential for deleterious effects of EDC must be considered relative to the regulation of hormone synthesis, secretion, and actions and the variability in regulation of these events across the life cycle. The developmental age at which EDC exposures occur is a critical consideration in understanding their effects. Because endocrine systems exhibit tissue-, cell-, and receptor-specific actions during the life cycle, EDC can produce complex, mosaic effects. This complexity causes difficulty when a static approach to toxicity through endocrine mechanisms driven by rigid guidelines is used to identify EDC and manage risk to human and wildlife populations. We propose that principles taken from fundamental endocrinology be employed to identify EDC and manage their risk to exposed populations. We emphasize the importance of developmental stage and, in particular, the realization that exposure to a presumptive "safe" dose of chemical may impact a life stage when there is normally no endogenous hormone exposure, thereby underscoring the potential for very low-dose EDC exposures to have potent and irreversible effects. Finally, with regard to the current program designed to detect putative EDC, namely, the Endocrine Disruptor Screening Program, we offer recommendations for strengthening this program through the incorporation of basic endocrine principles to promote further understanding of complex EDC effects, especially due to developmental exposures.

[1]  Zu-pei Chen,et al.  Developmental thyroid hormone disruption: prevalence, environmental contaminants and neurodevelopmental consequences. , 2012, Neurotoxicology.

[2]  Albrecht Poth,et al.  Implementation challenges for designing integrated in vitro testing strategies (ITS) aiming at reducing and replacing animal experimentation. , 2012, Toxicology in vitro : an international journal published in association with BIBRA.

[3]  D. Melzer,et al.  Urinary Bisphenol A Concentration and Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women , 2012, Circulation.

[4]  Laura N. Vandenberg,et al.  Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. , 2012, Endocrine reviews.

[5]  J. Gustafsson,et al.  Rapid Insulinotropic Action of Low Doses of Bisphenol-A on Mouse and Human Islets of Langerhans: Role of Estrogen Receptor β , 2012, PloS one.

[6]  M. Katoh,et al.  Metabolite profiling and identification in human urine after single oral administration of DEHP. , 2012, The Journal of toxicological sciences.

[7]  Jun Wang,et al.  Chronic Oral Exposure to Bisphenol A Results in a Nonmonotonic Dose Response in Mammary Carcinogenesis and Metastasis in MMTV-erbB2 Mice , 2011, Environmental health perspectives.

[8]  Robert J Kavlock,et al.  Developmental toxicity testing for safety assessment: new approaches and technologies. , 2011, Birth defects research. Part B, Developmental and reproductive toxicology.

[9]  F. Wania,et al.  INVESTIGATING INTERGENERATIONAL DIFFERENCES IN HUMAN PCB EXPOSURE DUE TO VARIABLE EMISSIONS AND REPRODUCTIVE BEHAVIOURS , 2011 .

[10]  M. Gilbert Neurodevelopmental Consequences of Low-Level Thyroid Hormone Disruption Induced by Environmental Contaminants , 2011 .

[11]  R. Zoeller,et al.  Individual polychlorinated biphenyl (PCB) congeners produce tissue- and gene-specific effects on thyroid hormone signaling during development. , 2011, Endocrinology.

[12]  Paloma Alonso-Magdalena,et al.  Endocrine disruptors in the etiology of type 2 diabetes mellitus , 2011, Nature Reviews Endocrinology.

[13]  Richard A Becker,et al.  Evaluation of EPA's Tier 1 Endocrine Screening Battery and recommendations for improving the interpretation of screening results. , 2011, Regulatory toxicology and pharmacology : RTP.

[14]  A. Gore,et al.  Transgenerational neuroendocrine disruption of reproduction , 2011, Nature Reviews Endocrinology.

[15]  J. Katzenellenbogen,et al.  Exploration of Dimensions of Estrogen Potency , 2011, The Journal of Biological Chemistry.

[16]  A. Moon,et al.  Essential roles of androgen signaling in Wolffian duct stabilization and epididymal cell differentiation. , 2011, Endocrinology.

[17]  F. Wania,et al.  Investigating Intergenerational Differences in Human PCB Exposure due to Variable Emissions and Reproductive Behaviors , 2010, Environmental health perspectives.

[18]  H. Patisaul,et al.  Neuroendocrine disruption: Historical roots, current progress, questions for the future , 2010, Frontiers in Neuroendocrinology.

[19]  W. Miyazaki,et al.  Disruption of Thyroid Hormone Receptor–Mediated Transcription and Thyroid Hormone–Induced Purkinje Cell Dendrite Arborization by Polybrominated Diphenyl Ethers , 2010, Environmental health perspectives.

[20]  J. Russo,et al.  In Utero Exposure to Bisphenol A Shifts the Window of Susceptibility for Mammary Carcinogenesis in the Rat , 2010, Environmental health perspectives.

[21]  N. Ben-Jonathan,et al.  Novel roles of prolactin and estrogens in breast cancer: resistance to chemotherapy. , 2010, Endocrine-related cancer.

[22]  I. Quesada,et al.  Bisphenol A Exposure during Pregnancy Disrupts Glucose Homeostasis in Mothers and Adult Male Offspring , 2010, Environmental health perspectives.

[23]  Cheryl S Watson,et al.  REVIEW Nongenomic Signaling Pathways of Estrogen Toxicity , 2010 .

[24]  B. Borrell Toxicology: The big test for bisphenol A , 2010, Nature.

[25]  G. Shaw,et al.  Wolffian duct differentiation by physiological concentrations of androgen delivered systemically. , 2009, Developmental biology.

[26]  L Earl Gray,et al.  Pubertal administration of DEHP delays puberty, suppresses testosterone production, and inhibits reproductive tract development in male Sprague-Dawley and Long-Evans rats. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[27]  S. Charlton Agonist efficacy and receptor desensitization: from partial truths to a fuller picture , 2009, British journal of pharmacology.

[28]  Erik Ropstad,et al.  Reproductive and Developmental Toxicity of Phthalates , 2009, Journal of toxicology and environmental health. Part B, Critical reviews.

[29]  C. Gray,et al.  Transgenerational effects of Di (2-ethylhexyl) phthalate in the male CRL:CD(SD) rat: added value of assessing multiple offspring per litter. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[30]  D. Jacobs,et al.  Kinetic and thermodynamic characterization of dihydrotestosterone-induced conformational perturbations in androgen receptor ligand-binding domain. , 2009, Molecular endocrinology.

[31]  L. Giudice,et al.  Endocrine-disrupting chemicals: an Endocrine Society scientific statement. , 2009, Endocrine reviews.

[32]  D. Gašperíková,et al.  Multiple adverse thyroid and metabolic health signs in the population from the area heavily polluted by organochlorine cocktail (PCB, DDE, HCB, dioxin) , 2009, Thyroid research.

[33]  Michael A. Kamrin,et al.  Phthalate Risks, Phthalate Regulation, and Public Health: A Review , 2009, Journal of toxicology and environmental health. Part B, Critical reviews.

[34]  R. Newbold,et al.  Prenatal Exposure to Bisphenol A at Environmentally Relevant Doses Adversely Affects the Murine Female Reproductive Tract Later in Life , 2009, Environmental health perspectives.

[35]  Jose Russo,et al.  Oral Exposure to Bisphenol A Increases Dimethylbenzanthracene-Induced Mammary Cancer in Rats , 2009, Environmental health perspectives.

[36]  Michael K. Skinner,et al.  Transgenerational Epigenetic Programming of the Brain Transcriptome and Anxiety Behavior , 2008, PloS one.

[37]  W. Miyazaki,et al.  Identification of the Functional Domain of Thyroid Hormone Receptor Responsible for Polychlorinated Biphenyl–Mediated Suppression of Its Action in Vitro , 2008, Environmental health perspectives.

[38]  E. Stefani,et al.  Pancreatic Insulin Content Regulation by the Estrogen Receptor ERα , 2008, PloS one.

[39]  C. Sonnenschein,et al.  Does breast cancer start in the womb? , 2008, Basic & clinical pharmacology & toxicology.

[40]  Julia A. Taylor,et al.  Low Phytoestrogen Levels in Feed Increase Fetal Serum Estradiol Resulting in the “Fetal Estrogenization Syndrome” and Obesity in CD-1 Mice , 2007, Environmental health perspectives.

[41]  R. Sharpe,et al.  The critical time window for androgen-dependent development of the Wolffian duct in the rat. , 2007, Endocrinology.

[42]  C. Sonnenschein,et al.  Induction of mammary gland ductal hyperplasias and carcinoma in situ following fetal bisphenol A exposure. , 2007, Reproductive toxicology.

[43]  R. Zoeller,et al.  Current and Potential Rodent Screens and Tests for Thyroid Toxicants , 2007, Critical reviews in toxicology.

[44]  R. Zoeller,et al.  4-Hydroxy-PCB106 acts as a direct thyroid hormone receptor agonist in rat GH3 cells , 2006, Molecular and Cellular Endocrinology.

[45]  Carlos Sonnenschein,et al.  Prenatal Bisphenol A Exposure Induces Preneoplastic Lesions in the Mammary Gland in Wistar Rats , 2006, Environmental health perspectives.

[46]  K. Coser,et al.  Importance of dosage standardization for interpreting transcriptomal signature profiles: Evidence from studies of xenoestrogens , 2006, Proceedings of the National Academy of Sciences.

[47]  Frederick S vom Saal,et al.  Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. , 2006, Endocrinology.

[48]  D. Sassoon,et al.  PCBs Exert an Estrogenic Effect through Repression of the Wnt7a Signaling Pathway in the Female Reproductive Tract , 2006, Environmental health perspectives.

[49]  Paul M D Foster,et al.  Disruption of reproductive development in male rat offspring following in utero exposure to phthalate esters. , 2006, International journal of andrology.

[50]  M. Koster,et al.  The History of DES, Lessons to be Learned , 2005, Pharmacy World and Science.

[51]  Kristina A Thayer,et al.  Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity. , 2003, Environmental health perspectives.

[52]  D. Burgin PCBs: Recent Advances in Environmental Toxicology and Health Effects , 2002 .

[53]  A. Kortenkamp,et al.  Combining xenoestrogens at levels below individual no-observed-effect concentrations dramatically enhances steroid hormone action. , 2002, Environmental health perspectives.

[54]  C. Klaassen,et al.  Effects of Microsomal Enzyme Inducers on Thyroid Follicular Cell Proliferation and Thyroid Hormone Metabolism , 2001, Toxicologic pathology.

[55]  C. Klaassen,et al.  Effects of microsomal enzyme inducers on thyroid-follicular cell proliferation, hyperplasia, and hypertrophy. , 1999, Toxicology and applied pharmacology.

[56]  R. Putzrath,et al.  Fundamentals of Health Risk Assessment. Use, Derivation, Validity and Limitations of Safety Indices , 1999, Risk analysis : an official publication of the Society for Risk Analysis.

[57]  D. Gaylor,et al.  No threshold dose for estradiol-induced sex reversal of turtle embryos: how little is too much? , 1999, Environmental health perspectives.

[58]  L. Hansen Stepping backward to improve assessment of PCB congener toxicities. , 1998, Environmental health perspectives.

[59]  Rosalind,et al.  Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop. , 1996, Environmental health perspectives.

[60]  J. Heltshe,et al.  Comparisons of patterns of polychlorinated biphenyl congeners in water, sediment, and indigenous organisms from New Bedford Harbor, Massachusetts , 1995 .

[61]  B. M. Hegde Textbook of Endocrine Physiology , 1994 .

[62]  P. Stewart,et al.  Licorice inhibits 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid levels and potentiates glucocorticoid hormone action. , 1993, Endocrinology.

[63]  J. Clarke,et al.  Environmental occurrence, abundance, and potential toxicity of polychlorinated biphenyl congeners: considerations for a congener-specific analysis. , 1989, Environmental health perspectives.

[64]  W. Welshons,et al.  Adaptation of estrogen-dependent MCF-7 cells to low estrogen (phenol red-free) culture. , 1987, European journal of cancer & clinical oncology.

[65]  荒瀬 栄樹 Endocrine disrupter bisphenol A increases in situ estrogen production in the mouse urogenital sinus , 2011 .

[66]  W. Miyazaki,et al.  The effect of hydroxylated polychlorinated biphenyl (OH-PCB) on thyroid hormone receptor (TR)-mediated transcription through native-thyroid hormone response element (TRE). , 2010, Industrial health.

[67]  W. Welshons,et al.  Large effects from small exposures. II. The importance of positive controls in low-dose research on bisphenol A. , 2006, Environmental research.

[68]  D. Sheehan No-threshold dose-response curves for nongenotoxic chemicals: findings and applications for risk assessment. , 2006, Environmental research.

[69]  D. Carpenter Polychlorinated Biphenyls (PCBs): Routes of Exposure and Effects on Human Health , 2006, Reviews on environmental health.

[70]  Terri Damstra,et al.  Global assessment of the state-of-the-science of endocrine disruptors , 2002 .

[71]  C. Waller,et al.  Molecular determinants of hormone mimicry: halogenated aromatic hydrocarbon environmental agents. , 1998, Journal of toxicology and environmental health. Part B, Critical reviews.

[72]  S. Ojeda,et al.  Textbook of endocrine physiology , 1992 .